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Abstract: Monocyclic b-lactams revive the research field on antibiotics, which are threatened by the emergenceo f resistant bacteria. As ix-step synthetic route was developed, providing easy access to new 3-amino-1-carboxymethyl-4-phenyl-b-lactams, of which the penicillin-binding protein (PBP) inhibitory potency was demonstrated biochemically.
In light of the rapidly escalating bacterial resistance problem, antibiotic discoveryr emains ah ighly important drug discovery endeavour. [1] To break away from traditional bicyclic b-lactam scaffolds, the research on monocyclic b-lactam antibiotics gains in importance, as we previously demonstrated through a three-decade literature overview. [2] Ta king into accountt he assembled state-of-the-art, and combining the structural properties of aztreonam (the only FDA-approved monobactam), the nocardicins (the first described, natural monocyclic b-lactams) and late-generation cephalosporins, our group recently studied an ew pharmacophore 1 to mimic d-alanyl-d-alanine, the natural substrate of the penicillin-bindingp roteins, playing ac rucial role in the bacterial cell wall biosynthesis (Figure 1 ). Using a virtual screening approacha sa no nset,aten-step synthetic pathway was developed towards am odel libraryo f4 -unsubstituted b-lactams 1,c haracterisedb yd iverse side chains 'R'. a-Benzylidene-substituted analogue 1A wasp romoted to become our first hit, favoured with promising PBP inhibitory activity and high b-lactamase stability.I no rder to gain addi-tional insights in the chemistry and structure-activity relationships of these complex b-lactams, an explorative study on synthetic routes towards C4-substituted analogues 2 was now initiated, holdingo nt ot he same design objectives ( Figure 1 ). In light of synthetic feasibility,4 -phenyl-b-lactams 2 were targeted first to provide ap roof of concept. Their synthesis was perceived to be achievable throughf unctionalisation, in as imilar way as previously described, [3] of 3-amino-1-carboxymethyl-blactams. As opposedt oC 4-unsubstituted b-lactams,C 4-substituted variants can be easily preparedv ia Staudinger's keteneimine [2+ +2]-cyclocondensation. [4] To date, this is one of the most renowned and versatile methods for the construction of the four-membered amide ring system and is often selected for its simplicity in reactionp rocedures and predictabilityo f the stereochemical outcome. [5] For the synthesis of 3-amino-blactamss pecifically,p hthalimido-(FtN) and azido-containing ketenes are typicallye mployed. [6] As am eans to shortent he synthetic pathway as much as possible, the variable side chain 'R' could be introduced directly in the amine part of the imine. Indeed, when protected a-aminoa cids would be used as cheap and easily available substrates and condensed with benzaldehyde, the a-functionalised carboxymethyl moiety could be installed quite easily onto the resulting b-lactam N1-position. Based on the in silico design criteria regarding the a-side chain 'R' (Figure 1c ), [3] several divergent a-amino acids were selected to i. optimise the synthetic procedures (l-/dl-Phe); ii. introduce terminal hydrogen bond donors or acceptors (l-Glu, l-Trpa nd l-/d-Met, for oxidation to sulphones);a nd iii. change the linker type to aromatic nocardicin-like motifs (d-Phg) . [2] Ta king all the above into account, l-phenylalanine 3A (R = Bn) as am odel substrate was converted to the corresponding methyl ester 4A by meanso f2 ,2-dimethoxypropane and hydrochlorica cid (Method A,S cheme 1, Table 1 ). The resulting amine HCl salt wasc onverted to the free base and subsequently condensed with benzaldehyde,a ffording aldimine 5A in quantitative yield (Method C). Also the racemic starting material 3A' (dl-Phe) was converted in this way in view of HPLC analysisu sing ac hiral stationary phase ('chiral HPLC')a talater stage. Meanwhile, N-phthaloylglycine 6 was converted to the corresponding glycyl chloride 7.A fter dehydrochlorinationo f acid chloride 7 using triethylamine, the in situ generated ketene was coupled with imines 5A-A' to yield 4-phenyl-3phthalimidoazetidin-2-ones 8A-A'.P rofound variation of the Staudinger reaction conditions wasn ecessary to enhance the conversion rate andyield. The optimised set of reactionparameters and corresponding reaction outcomes are displayed in Ta ble 1. As expected, comparison of the resultso fMethods E and F,s howed that ah igher amount of trans-isomerw as ob-tained when 2,6-lutidine was used as ab ase in boiling toluene. [5] The accessibility of both cis-a nd trans-isomers was considered an asset with respect to future evaluationo ft he biological potency of the corresponding target products 2.
Next, phthaloyl deprotection of compounds 8A-A' using hydrazine hydrate furnished 3-aminoazetidin-2-ones 9A-A' (Table 2, Scheme 2). [7] In the next step, the obtained free amines werec oupled with 2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid (2-ATMO, predominantly syn)i na lkaline environment using O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TBTU) as ac oupling reagent. The resulting cyclic amides 10A-A' wereo btained in variable yields of 35-69 %a fter conventional purification techniques. Additional separation of the obtained diastereomericm ixtures via preparative HPLCp ermitted to isolate the individual diastereomers 10A 1 , 10A 2 and 10A' 1 , 10A' 2 (all trans). The isolated isomers were used to assess the opticalp urity of the compounds with respectt ot he a-position after the different reaction steps via chiral HPLC. This technique, however,d emonstrated al ow enantiomeric excess (6 %) forc ompounds 10A 1 and 10A 2 , which implied epimerisationo ft he a-position of the methyl ester derived from optically pure l-phenylalanine. Retrospective analysis of all intermediates revealed that epimerisation took place already during imination (Scheme 1, Table 1 , Method C), whichisnot in accordancewith preceding literature reports, stating conservation of the chirality of similara mino acid-derived iminesu sing comparable or even harsher reaction conditions (alkaline environment, elevated temperatures). [8] For this reason, an ew imination procedure was tested (Method D), which did give rise to imine 5A with ac onsiderably higher ee of 86 %. [9] Consequently,t his method was appliedf or the synthesis of the other derivatives 5,8-10B-E as well. As such, our target library was enlarged by converting the above-mentioned a-amino acids 3B-E to b-lactams 10B-E via similar chemicalt ransformations( Scheme1,S cheme 2, Table 1 , Ta ble 2). Despite the (presumed) use of chiral imines,amore or less equimolar amount of the two trans-isomers 8B-E was obtainedi ne ach case, which is in good agreement with the statementt hat ac hiral imine derived from ac hiral amine and an achiral aldehyde is not an appropriate chiral inductor in the Staudinger synthesis. [10] Both l-a nd d-methionine 3D-D' were employed individually to be able to use the enriched mixtures of compounds 10D-D' for chiral HPLC methodo ptimisation and determine if the configuration of the chiral centre in a-position of the carboxylic acid was now conserved throughout the pathway (Table 2) . When compared with l-Phe-derived blactams 10A (synthesised using imination MethodC , Table 1 , ee = 6%), the epimerisation issue of most other derivatives was far more limited (e.g., ee > 76 %f or 10D', Method D). As expected, only d-Phg-derived compounds 5,8-10E were completely racemised as ar esult of the formation of an extensive conjugated system after deprotonation at the benzylic position. [11] In previousw ork, [3] it was shownt hat epimerisation at the a-position can also take place during subsequent hydrolysis, depending on the reagent used. The deprotection reaction of diastereomerically pure trans ester 10A 1 using LiOH·H 2 O indeed caused slight epimerisation (MethodA ,T able 2). S N 2type dealkylation with LiI resulted in high stereoselectivity but Scheme2.Functionalisation of key intermediates 8 towards target products 11.
Chem. Asian J. 2020, 15, [51] [52] [53] [54] [55] www.chemasianj.org lower conversion (Method B). Similar resultsw ere obtainedf or the racemic analogues 10A'.I ne ither way,t he loss of enantiopurity at the a-position was not am ajor issue as long as the biological potency of these compounds hadn ot been proven. Analogues 10B-E were therefore hydrolysed using the LiOHmediated procedure. As mentioned before,i nc ase of methionine-derived analogues 10D-D',s ulphide oxidation was performed prior to hydrolysis using meta-chloroperbenzoic acid to bring along the insertiono ft wo additional hydrogen bond acceptorsi nat erminal position, which is one of the premised design requirements (Figure 1 ). [3, 12] Sulphones 10F-F' were obtained in this way withouts ignificant loss of enantiopurity at the a-position (ee(10F trans ) = 85 %, Ta ble 2), and could subsequently be hydrolysed in quantitative yields relyingo nL iOH·H 2 O. As such, this pathway enabled the preparation of as et of novel cis-a nd/or trans-3-acetamido-1-carboxymethyl-4-phenylazetidin-2-ones 11 in al imited amount of six (or seven for 11F-F')s teps in up to 30 %o verall yield, remarkably more efficient comparedw ith the synthesis of their C4-unsubstituted analogues (ten steps, up to 2% overall yield). [3] The reactants cope of the synthetic pathway can be expanded towards other aromatic or aliphatic aldehydes,c ombined with readily available (un)natural a-aminoacids, if desired.
In order to provide some preliminary data on the biological potentialo ft his series of functionalised 3-amino-1-carboxymethyl-b-lactams 2 (after neutralisation of 11 with HCl to provide the corresponding carboxylic acids), the compounds were subjected to aPBP binding and competition assay.The purified PBP3 of E. coli K12,P BP5fm of E. faecium D63r and R39 DD-carboxypeptidase of Actinomaduraspp. [13] were incubated with acids 2,a fter which their residual activity (%RA) was determined by labelling the free enzymes with BocillinF L, af luorescent reporter molecule and penicillinVanalogue ( Table 3 ). [14] The results revealed the remarkably low residual activity of PBP3 (10 %R A), al ethal target of E. coli,p rovoked by compound 2E trans .T he inhibitory potency is higher than that of our initial hit 1A (28 %R A), [3] confirming the potentialo fC4-substituted, a-aromatic-andt herefore nocardicin-like-3-amino-1-carboxymethyl b-lactam scaffoldsf or furtherP BP inhibitor design. The unprecedented and highly straightforward six-step synthetic route described in this work, converting simple substrates into highly functionalised C4-(phenyl-)substituted nocardicin analogues, might therefore be used to further guide expansion studies in the future startingf rom 1-carboxymethylb-lactam 2E trans as apromisingn ew hit structure (Figure 2 ). [a] Computed from literatured ata. [15] [b] Aztreonam is not active against Gram-positive bacteria.
[c] Computed from literature data. [16] [d] Indicatory value due to low solubility at > 0.8 mm. 
